Cargando…
Impact of Drug Administration Routes on the In Vivo Efficacy of the Natural Product Sorangicin a Using a Staphylococcus aureus Infection Model in Zebrafish Embryos
Staphylococcus aureus causes a wide range of infections, and it is one of the leading pathogens responsible for deaths associated with antimicrobial resistance, the rapid spread of which among S. aureus urges the discovery of new antibiotics. The evaluation of in vivo efficacy of novel drug candidat...
Autores principales: | Fries, Franziska, Kany, Andreas M., Rasheed, Sari, Hirsch, Anna K. H., Müller, Rolf, Herrmann, Jennifer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454396/ https://www.ncbi.nlm.nih.gov/pubmed/37628971 http://dx.doi.org/10.3390/ijms241612791 |
Ejemplares similares
-
Zebrafish: An Attractive Model to Study Staphylococcus aureus Infection and Its Use as a Drug Discovery Tool
por: Rasheed, Sari, et al.
Publicado: (2021) -
Sorangicin A Is Active against Chlamydia in Cell Culture, Explanted Fallopian Tubes, and Topical In Vivo Treatment
por: Graspeuntner, Simon, et al.
Publicado: (2023) -
Natural Products Lysobactin and Sorangicin A Show In Vitro Activity against Mycobacterium abscessus Complex
por: Sullivan, Jaryd R., et al.
Publicado: (2022) -
Drug Administration Routes Impact the Metabolism of a Synthetic Cannabinoid in the Zebrafish Larvae Model
por: Park, Yu Mi, et al.
Publicado: (2020) -
Spatiotemporal imaging and pharmacokinetics of fluorescent compounds in zebrafish eleuthero-embryos after different routes of administration
por: Guarin, Marlly, et al.
Publicado: (2021)